The effect of anesthetic blockade of greater occipital nerve during the withdrawal period of the medication overuse headache treatment

• Published in: Ideggyógyászati szemle Vol. 77; no. 3-4; p. 103
• Main Authors: Mirac, Unsal Aysen, Tugrul, Aydin
• Format: Journal Article
• Language: English
• Published: Hungary 30.03.2024
• Subjects: Anesthetics - therapeutic use; Bupivacaine - therapeutic use; Headache; Headache Disorders, Secondary - chemically induced; Headache Disorders, Secondary - drug therapy; Humans; Migraine Disorders - drug therapy; medication overuse headache; migraine; nerve blockade; chronic daily headache; primary headache; chronic migraine; greater occipital nerve blockade; secondary headache
• ISSN: 0019-1442
• DOI: 10.18071/isz.77.0103

Discontinua­tion of medication still remains a key element in the treatment of medication overuse headache (MOH), but there is no consensus on the withdrawal procedure. We aimed to share the promising results of anesthetic blockade of greater occipital nerve (GON), which can be an alternative to existing treatments during the early withdrawal period of MOH treatment.. This study was conducted using regular electronic medical records and headache diaries of patients diagnosed with MOH and treated with anesthetic GON blockade with 0.5% bupivacaine solution in a specia­lized headache outpatient clinic. A total of 86 patients who developed MOH while being followed up for chronic migraine were included in the study.. The treatment schemes for MOH are based on expert consensus and withdrawal strategies are the most challenging part of treatment. In our study, numerical rating scale for headache intensity, overused medication consumption per month, headache frequency (day/month) and the duration of each attack (hour/day) decreased significantly in the first month compared to pre-treatment (p < 0.01). . Conclusion - Our study suggests that GON blockade can be used as a good alternative therapy in the treatment of MOH..